Trial Profile
A phase I/II, open-label, multi-center study of the pharmacokinetics, safety, tolerance and activity of two dose levels of adefovir dipivoxil (ADF) and nelfinavir when added to antiretroviral therapy for the treatment of HIV-infected pediatric patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2005
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Antiretrovirals; Nelfinavir
- Indications HIV infections
- Focus Therapeutic Use
- 20 Oct 2005 New trial record.